J
Jee Hyun Kim
Researcher at Seoul National University Bundang Hospital
Publications - 703
Citations - 12600
Jee Hyun Kim is an academic researcher from Seoul National University Bundang Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 46, co-authored 319 publications receiving 9907 citations. Previous affiliations of Jee Hyun Kim include Seoul National University & New Generation University College.
Papers
More filters
Journal ArticleDOI
Identification of a potentially avoidable cardiopulmonary resuscitation in hematology and oncology wards.
Yeonjoo Choi,Yeonjoo Choi,Yeonjoo Choi,Jin Won Kim,Koung Jin Suh,Yoo Joo Lim,Yoo Joo Lim,Ji Yun Lee,Beodeul Kang,Ji Won Kim,Se Hyun Kim,Jeong Ok Lee,Yu Jung Kim,Keun Wook Lee,Jee Hyun Kim,Soo Mee Bang,Jong Seok Lee +16 more
TL;DR: A potentially avoidable CPR was common at hematology and oncology wards and frequently occurred in advanced diseases and certain tumor types, and cancer patients who received a potentiallyavoidable CPR showed the worse prognosis.
Journal ArticleDOI
Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trial.
Sung Bae Kim,Changhoon Yoo,Jungsil Ro,Seock-Ah Im,Young-Hyuck Im,Jee Hyun Kim,Jin-Hee Ahn,Kyung Hae Jung,Hong Suk Song,Seok Yun Kang,Hee Sook Park,Hyun Cheol Chung +11 more
TL;DR: Although both regimens were well tolerated, grade 3/4 non-hematologic toxicity was more frequently observed in the TSU-68 plus docetaxel group, it should be further explored in this subgroup.
Journal ArticleDOI
A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma.
Dae Won Lee,Kyung Hun Lee,Hee Jun Kim,Tae Yong Kim,Tae Yong Kim,Jin Soo Kim,Sae-Won Han,Sae-Won Han,Do Youn Oh,Do Youn Oh,Jee Hyun Kim,Seock-Ah Im,Seock-Ah Im,Tae-You Kim,Tae-You Kim +14 more
TL;DR: Although this trial did not meet its primary end point, the SOX regimen showed comparable efficacy and safety to the 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) regimen.
Journal ArticleDOI
Gemcitabine and Vinorelbine Combination Chemotherapy in Anthracycline- and Taxane-pretreated Advanced Breast Cancer
Hye Jin Kim,Jin Soo Kim,Myung-Deok Seo,So-Yeon Oh,Do-Youn Oh,Jee Hyun Kim,Se-Hoon Lee,Dong Wan Kim,Seock-Ah Im,Tae-You Kim,Dae Seog Heo,Yung-Jue Bang +11 more
TL;DR: Although the efficacy was unsatisfactory in patients with both anthracycline and taxane primary resistance, gemcitabine and vinorelbine combination chemotherapy showed comparable efficacy in anthrACYcline- and/or taxane-sensitive patients and the patients with secondary resistance, even after failure of second-line therapy.